Glossary

national drug code

The National Drug Code is the identifier a drug package carries in three segments — labeler, product, package. Labels print it as 10 digits in one of three layouts; billing systems key on an 11-digit padded form.

Also written: NDC, NDC number

The National Drug Code (NDC) is the number that identifies a specific drug package in the United States. It has three segments — the labeler code, which FDA assigns to the manufacturer or repackager; the product code, which the labeler assigns to a strength and dosage form; and the package code, which distinguishes the bottle size or the unit-dose blister. The labeler and the product together describe the drug; the package code is what makes the NDC a package identifier rather than a drug identifier.

An NDC is printed on the label as 10 digits in one of three layouts — 4-4-2, 5-3-2 or 5-4-1 — and billed in exactly one, the 11-digit 5-4-2 form, made by padding the short segment with a leading zero. That padding step is the arithmetic the exam tests: read the label's layout, find the segment that is one digit short, add the zero there, and rejoin as 5-4-2.

Three consequences follow. One drug has many NDCs — every labeler, every package size and every repackager gets its own — so an NDC identifies a package and not a molecule. The NDC is not the price and not the therapeutic substitute: two products with different NDCs may be interchangeable, and two with the same drug name may not be. And the code is a technical identifier with its own FDA rule; the labeler/product/package structure is governed by 21 CFR 207.33, which FDA revised in a final format rule published March 5, 2026. When a claim rejects, the NDC is usually the first field to check.

Source: PTCB — PTCE Content Outline, effective January 6, 2026 (the KA 1.2 statement "Therapeutic duplications", the KA 2.2 and 2.3 statements on controlled substances and prescription requirements, the KA 4.3 and 4.4 statements on NDC, lot, expiration and returns, and the KA 3.1/3.2 error-prevention statements, quoted verbatim); FDA label and NDC data read through openFDA and DailyMed; ISMP (the high-alert medication definition and the error-prone abbreviation list); USP <795> and <797>; the DEA Pharmacist's Manual (outline accessed 2026-10-03, verbatim; every fact below restates this course's own guides, which carry the per-source citations on their own pages (FDA, ISMP, USP and DEA each publish on its own schedule))

← All PTCB glossary terms

Study for the PTCB with us — free practice sets and topic guides